Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Carl Zeiss Vision forecasts $1.04 billion
Aalen, Germany—Carl Zeiss Vision—the newly formed company established by the merger of Carl Zeiss Ophthalmic Lens Division and SOLA International Inc.—will be headquartered here under the direction of former SOLA Chief Executive Officer Jeremy C. Bishop.
Related Videos
Related Content
